Eyeing growth in regenerative medicine, Fujifilm spends $800M on two new members of its CDMO business
In a sign that it’s doubling-down on the contract manufacturing and development business, Japan’s Fujifilm is paying $800 million to acquire two companies specializing in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.